FindTrial
Sign In

A multicenter prospective cohort study to optimize diagnosis and evaluation of heart failure with preserved ejection fraction

A multicenter prospective cohort study to optimize diagnosis and evaluation of heart failure with preserved ejection fraction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058794
Enrollment
Unknown
Registered
2022-04-17
Start date
2022-04-26
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

None listed

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 to 85 years; 2. Heart failure stage B to D.

Exclusion criteria

Exclusion criteria: 1. Left ventricular ejection fraction <= 40%; 2. Acute myocardial infarction within 1 month before inclusion; 3. Acute infectious disease; 4. Inability or refusal to sign informed consent; 5. Inability to cooperate to complete questionnaires and follow up on schedule for various reasons (severe cognitive impairment, deafness, non-Chinese, etc.).

Design outcomes

Primary

MeasureTime frame
heart failure and deterioration of heart failure;A composite end point of cardiovascular death and transition to clinical heart failure for stage B;A composite end point of cardiovascular death and hospitalization for heart failure for stage C or D;—

Countries

China

Contacts

Public ContactHua Wang

Beijing Hospital

wh74220@aliyun.com+86 13911680467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026